Skip to content

The effect of Fasting-mimicking diets on polycystic ovary syndrome

Randomized controlled trial for fasting-mimicking diets in patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071796
Enrollment
Unknown
Registered
2023-05-25
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

control:Nil
Interventional group:fasting-mimicking diet

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Female patients who meet the diagnostic criteria for PCOS in the Diagnostic Criteria and Treatment Specifications for Polycystic Ovary Syndrome formulated by Chinese experts in 2011; 2. Aged 18-40 (Inclusion boundary value); 3. BMI: 20-40 kg/m2 (Inclusion boundary value); 4. Patients who are willing to accept the diet intervention program; 5. Patients who volunteered to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with thyroid disease, adrenal disease, hyperprolactinemia, pituitary tumor and/or other diseases causing hyperandrogenic and non-ovulation. Or combined with cardiovascular disease, liver and kidney insufficiency, malignant tumor, type 1 or type 2 diabetes and/or other chronic diseases; 2. Patients with medical histories of long-acting hormone drugs and drugs affecting metabolism 3 months before treatment; 3. Patients receiving ovulation-promoting drugs; 4. Lactating women; 5. Vulnerable groups, including mental illness, cognitive impairment, critically ill patients, juveniles, pregnant women, illiterates, etc.

Design outcomes

Primary

MeasureTime frame
Recovery of menstrual patterns;

Secondary

MeasureTime frame
luteinizing hormone (LH);follicle-stimulating hormone (FSH);Estradiol (E2);Testosterone (T);Prolactin (PRL);progesterone (PROG);Fasting insulin (FINS);Fasting Plasma Glucose;Total cholesterol (TC);Triglyceride (TG);high density lipoprotein (HDL);low density lipoprotein (LDL);Insulin resistance index (HOMA-IR);

Countries

China

Contacts

Public ContactLijun Feng

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

3191030@zju.edu.cn+86 571 8600 6451

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026